GL1X · GenesisL1 explorer

Research workbench

Structure-based design and synthesis of novel macrocyclic PYRAZOLO[1, 5-a] [1,3,5]TRIAZINE compounds as potent inhibitors of protein kinase CK2 and their anticancer activities

Analyse Structure-based design and synthesis of novel macrocyclic PYRAZOLO[1, 5-a]… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3BE9
Type
protein
Length
328 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Casein kinase II subunit alpha
EC
2.7.11.1
UniProt
P28523
Ligands
P04
Pockets
2 · best druggability 0.70

Structure

x-ray diffraction · 1 distinct chain · 43% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACasein kinase II subunit alpha (EC 2.7.11.1)protein32843% helix, 15% strandP28523

Ligands and binding sites

  • P04 · 19-(cyclopropylamino)-4,6,7,15-tetrahydro-5H-16,1-(azenometheno)-10,14-(metheno)pyrazolo[4,3-o][1,3,9]triazacyclohexadecin-8(9H)-one · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13940.700.8248P04
2570.340.7720empty

Modifications

Observed in the structure: 1 modified (oxidation).

Compared structures

  • 3BE9 · Structure-based design and synthesis of novel macrocyclic pyrazolo[1,5-a] [1,3,5]triazine… · the same entry in another collection · chain A against A, TM-score 1.00
  • P28523 · AlphaFold monomer V2.0 prediction for casein kinase II subunit alpha (P28523) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.